Latest news
Loading news…
Myalept
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. For Profit
A product designed to treat complications of leptin deficiency in patients with generalized lipodystrophy
Myalept on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Myalept was acquired by Aegerion Pharmaceuticals in 2014.
Last Funding
Acquisitions
0
Monthly Visits
Contacts
0
About Myalept
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 28
- IT spend
- $77.74K
Company Info
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 1
- Exit date
- Nov 6, 2014
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.3
- Trend (90d)
- 2.1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Myalept
Loading news…
FAQs about Myalept
People who checked this page also checked these
Browse the full Acquirezy directory.